恶性梗阻性黄疸的介入治疗

目的 :探讨介入治疗恶性梗阻性黄疸的临床价值。方法 :31例恶性梗阻性黄疸患者先行PTCD( 17例 )及金属支架置入术 ( 14例 ) ,1周后行肝动脉灌注化疗或栓塞治疗。结果 :31例PTCD或胆道内支架置入后 ,血清总胆红素下降。 2例患者 2个月内死于与本治疗无关的原因。 2例支架再狭窄。所有病例均获随访 ,平均生存 9个月 ,最长 2 6个月。结论 :介入治疗恶性梗阻性黄疸是一种有效的方法 ;介入治疗可以延长恶性梗阻性黄疸患者的生存时间。

Interventional Therapy of Malignant Obstructive Jaundice

Objective To study the clinical value of interventional therapy for malignant obstructive jaundice.Methods Total of 31 cases patients with malignant obstructive jaundice were treated by percutaneous transhepatic cholangiography and drainage (PTCD 17 cases) or metallic stent insertion (14 cases),all of cases were also treated by Hepatic artery infusing chemotherapy or embolization after PTCD and metallic stent insertion.Results Total bilirubin value was decreased in all cases post PTCD or stent inserton.Two cases died of none procedure relation within 2 month after the precedure.Two cases developed recurrent jaundice caused by stent re occluded.Follow up in all cases,the mean survival period was 9 months and the longest survival period was 26 months.Conclusion Interventional therapy was effective and also prolong the patients life in the treatment of malignant obstructive jaundice.